Share & more
As part of its ongoing "Secure The Future" initiative to tackle HIV/AIDS in Africa, pharmaceutical giant Bristol-Myers Squibb has announced the allocation of six new programme grants totalling US $30 million to the worst-affected countries in the continent.
According to a recent statement by the company, the new allocation makes this initiative the most significant corporate commitment to the HIV/AIDS crisis.
Bristol-Myers Squibb CEO, Peter Dolan, said: "Through Secure The Future, Bristol-Myers Squibb is helping to lead the global fight against the HIV/AIDS pandemic. Our programme has pioneered the development of public-private partnerships that are benefiting the hardest-hit populations in Africa, especially women and children."
Including the new allocation, the initiative had provided grants totalling $96 million to more than 150 programmes in nine countries in southern and western Africa.
"Secure The Future is establishing a new paradigm for combating the HIV/AIDS pandemic in Africa. The unique approach of offering both community and medical services is critically important to efforts to stem the devastation of this disease," Pearl Ntsekhe, a director in the Lesotho Ministry of Health and Social Welfare confirmed.
This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions